Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Characteristics of Patients Initiating Spiriva Respimat in Asthma in the UK: a Cross-sectional Study Based on the Clinical Practice Research Datalink

NCT03692676 is registered in ClinicalTrials.gov with Boehringer Ingelheim as lead sponsor.

NCT NCT03692676
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03692676 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Characteristics of Patients Initiating Spiriva Respimat in Asthma in the UK: a Cross-sectional Study Based on the Clinical Practice Research Datalink
Lead sponsor
Boehringer Ingelheim
Phase
Observational
Overall status
Completed
Start date
March 5, 2019
Completion date
October 11, 2019
Enrollment
Not reported
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

asthma